ArriVent BioPharma, Inc Common Stock
Price & Volume
Stats
See more52W Range | $15.47-$27.22 |
Market Cap | $947.2M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.32 |
News
See moreYahoo Finance • 24 days ago
ArriVent Biopharma, Inc. Full Year Loss Increases
Yahoo Finance • 3 months ago
ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer
Yahoo Finance • 6 months ago
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
Yahoo Finance • 8 months ago
ArriVent BioPharma Reports Second Quarter 2025 Financial Results
About
CEO | Dr. Zhengbin Yao Ph.D. |
CFO | Mr. Winston Kung M.B.A. |
Address | 18 Campus Boulevard, Newtown Square, PA, United States, 19073 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 77 |
